drugset / Trial / NCT07106021
A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease
Phase 1/2
Recruiting
12 enrolled
Kenai Therapeutics
California Institute for Regenerative Medicine (CIRM) · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.
Timeline
- Start
- 2025-07-17
- Primary completion
- 2027-09
- Completion
- 2031-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RNDP-001 | Cell therapy | — | Other |